Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

The YAG laser and Wallstent endoprosthesis for palliation of cancer in the esophagus or gastric cardia

Tranberg, K. G. LU ; Stael von Holstein, C. LU ; Ivancev, K. LU ; Cwikiel, W. LU and Lunderquist, A. LU (1995) In Hepato-Gastroenterology 42(2). p.139-144
Abstract

The need for frequent retreatment is a disadvantage of using endoscopic laser therapy (ELT) alone for palliative treatment of esophageal carcinoma. In this prospective study, therefore, we investigated the potential and feasibility of combining ELT with a self-expanding metallic stent (Wallstent). Twelve patients received ELT followed by stent placement (stent group) and were compared with 39 patients receiving ELT alone (ELT group). Swallowing ability was similar in the two groups. About one-third of the patients who had a short life expectancy, did not appear to benefit from stenting, whereas the interval between retreatments was prolonged by a factor of 2-4 in the remaining patients. Median survivals were 5.5 (range 1.0-23.5) months... (More)

The need for frequent retreatment is a disadvantage of using endoscopic laser therapy (ELT) alone for palliative treatment of esophageal carcinoma. In this prospective study, therefore, we investigated the potential and feasibility of combining ELT with a self-expanding metallic stent (Wallstent). Twelve patients received ELT followed by stent placement (stent group) and were compared with 39 patients receiving ELT alone (ELT group). Swallowing ability was similar in the two groups. About one-third of the patients who had a short life expectancy, did not appear to benefit from stenting, whereas the interval between retreatments was prolonged by a factor of 2-4 in the remaining patients. Median survivals were 5.5 (range 1.0-23.5) months in patients with stents, and 4.5 (range 1.2-24.6) months in patients without stents. There were few complications related to stenting. In one patient, technical problems caused stent dislodgement into the stomach. Another stent patient died of hemorrhage from an untreated tumor in the stomach, but it was considered unlikely that the bleeding was caused by the stent. In conclusion, this preliminary trial suggests that a Wallstent endoprosthesis, used in combination with laser treatment, may become a valuable tool for prolonging the dysphagia-free interval in selected patients.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Endoprosthesis, Esophagus, Laser therapy, Neoplasms, Self-expanding metallic stent
in
Hepato-Gastroenterology
volume
42
issue
2
pages
6 pages
publisher
Georg Thieme Verlag
external identifiers
  • pmid:7545639
  • scopus:0028989947
ISSN
0172-6390
language
English
LU publication?
yes
id
1173ad95-1bfb-48fc-bf18-e6d62ef869df
date added to LUP
2019-06-15 17:16:57
date last changed
2024-01-01 10:46:02
@article{1173ad95-1bfb-48fc-bf18-e6d62ef869df,
  abstract     = {{<p>The need for frequent retreatment is a disadvantage of using endoscopic laser therapy (ELT) alone for palliative treatment of esophageal carcinoma. In this prospective study, therefore, we investigated the potential and feasibility of combining ELT with a self-expanding metallic stent (Wallstent). Twelve patients received ELT followed by stent placement (stent group) and were compared with 39 patients receiving ELT alone (ELT group). Swallowing ability was similar in the two groups. About one-third of the patients who had a short life expectancy, did not appear to benefit from stenting, whereas the interval between retreatments was prolonged by a factor of 2-4 in the remaining patients. Median survivals were 5.5 (range 1.0-23.5) months in patients with stents, and 4.5 (range 1.2-24.6) months in patients without stents. There were few complications related to stenting. In one patient, technical problems caused stent dislodgement into the stomach. Another stent patient died of hemorrhage from an untreated tumor in the stomach, but it was considered unlikely that the bleeding was caused by the stent. In conclusion, this preliminary trial suggests that a Wallstent endoprosthesis, used in combination with laser treatment, may become a valuable tool for prolonging the dysphagia-free interval in selected patients.</p>}},
  author       = {{Tranberg, K. G. and Stael von Holstein, C. and Ivancev, K. and Cwikiel, W. and Lunderquist, A.}},
  issn         = {{0172-6390}},
  keywords     = {{Endoprosthesis; Esophagus; Laser therapy; Neoplasms; Self-expanding metallic stent}},
  language     = {{eng}},
  month        = {{06}},
  number       = {{2}},
  pages        = {{139--144}},
  publisher    = {{Georg Thieme Verlag}},
  series       = {{Hepato-Gastroenterology}},
  title        = {{The YAG laser and Wallstent endoprosthesis for palliation of cancer in the esophagus or gastric cardia}},
  volume       = {{42}},
  year         = {{1995}},
}